evolocumab
amgen
['evolocumab']
new results from the yellow iii study presented at #acc23 may improve understanding of evolocumab in the treatment of stable cad. learn more: 
Clinical News for Connected Physicians. Everything you need to enhance your clinical approach to improving patient care.